Year: 2023

Prosper Gold Corp. Closes Second Tranche of Private Placement and Prepares for Winter Drilling at Golden Sidewalk Project

Written by Customer Service on November 28, 2023. Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) — Prosper Gold Corp. (“Prosper Gold” or the “Company“) (TSXV:PGX) announces that it has mobilized a crew to the Golden Sidewalk Project (the “Project”) in northwest Ontario in preparation for winter diamond drilling. The Company further announces it has closed the second tranche (the “Second Tranche”) of the previously announced non-brokered private placement financing (the “Financing”) (i) of units (each, a “Unit”) and (ii) common shares of the Company that qualify as “flow through shares” for purposes of the Income Tax Act (Canada) (“FT Shares”). A crew has been mobilized to the Golden Sidewalk Project in the Red Lake Mining District, Northwest Ontario, to lay out drill pads and access roads. Up to 2,500 metres will be drilled at three previously...

Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit

Written by Customer Service on November 28, 2023. Posted in Public Companies.

EDISON, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”), and other chronic diseases, today announced that it will present at the 7th Obesity & NASH Drug Development Summit taking place November 27 – 29, 2023 in Boston. Scott Campbell, PhD, Hepion’s Quantitative Translational Pharmacologist, will deliver an oral presentation on the use of AI / machine learning (“ML”) to enrich NASH clinical trials and for NASH patient selection; and the use of multi-omics with ML for biomarker response prediction. Presentation details:Title: Using AI/ML and Multi-Omics to...

Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update

Written by Customer Service on November 28, 2023. Posted in Earnings Releases And Operating Results.

Product revenue for the nine months of 2023 increased to $29.8 million, compared to $11.1 million for the same period in 2022Marketing authorization was received for AVT04 in Canada and Japan, the first for a biosimilar to Stelara® (ustekinumab)The European Medicines Agency proposed market authorization for AVT04 in the 30 member states of the European Economic Area, pending a final decision by the European CommissionApprovability of AVT02 and AVT04 in the U.S. now pending satisfactory US Food and Drug Administration (FDA) inspection of Alvotech’s facility in Iceland, currently expected on January 10 – 19, 2024Management will conduct a business update conference call and live webcast on Wednesday November 29, 2023, at 8:00 am ET (13:00 pm GMT)REYKJAVIK, Iceland, Nov. 28, 2023 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO,...

Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update

Written by Customer Service on November 28, 2023. Posted in Earnings Releases And Operating Results.

Product revenue for the nine months of 2023 increased to $29.8 million, compared to $11.1 million for the same period in 2022 Marketing authorization was received for AVT04 in Canada and Japan, the first for a biosimilar to Stelara® (ustekinumab) The European Medicines Agency proposed market authorization for AVT04 in the 30 member states of the European Economic Area, pending a final decision by the European Commission Approvability of AVT02 and AVT04 in the U.S. now pending satisfactory US Food and Drug Administration (FDA) inspection of Alvotech’s facility in Iceland, currently expected on January 10 – 19, 2024 Management will conduct a business update conference call and live webcast on Thursday November 29, 2023, at 8:00 am ET (13:00 pm GMT)Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the...

Kane Biotech Announces Improved Third Quarter 2023 Financial Results

Written by Customer Service on November 28, 2023. Posted in Earnings Releases And Operating Results.

29% Increase in Product and Services Revenue; 26% Increase in Total Revenue WINNIPEG, Manitoba, Nov. 28, 2023 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2023 financial results. Third Quarter Financial Highlights:Revenue from product and services for the three months ended September 30, 2023 was $548,785 an increase of 29% from $425,671 in the three months ended September 30, 2022. This increase is due mainly to higher STEM Animal Health (STEM) online and pet retail sales in the current period. Royalty and license revenue for the three months ended September 30, 2023 was $169,067, an increase of 16% compared to $146,015 in the three months ended September 30, 2022. This increase is due mainly to incremental license revenue in the current period...

Leslie’s, Inc. Announces Fourth Quarter & Fiscal 2023 Financial Results; Provides Fiscal 2024 Outlook

Written by Customer Service on November 28, 2023. Posted in Earnings Releases And Operating Results.

Sales of $432.4 million in the fourth quarter and $1,451.2 million in Fiscal 2023 Net income of $16.5 million in the fourth quarter and $27.2 million in Fiscal 2023 Adjusted EBITDA of $59.5 million in the fourth quarter and $168.1 million in Fiscal 2023 Diluted earnings per share of $0.09 in the fourth quarter and $0.15 in Fiscal 2023 Adjusted diluted earnings per share of $0.14 in the fourth quarter and $0.28 in Fiscal 2023PHOENIX, Nov. 28, 2023 (GLOBE NEWSWIRE) — Leslie’s, Inc. (“Leslie’s”, “we”, “our” or “its”; NASDAQ: LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry, today announced its financial results for the fourth quarter and Fiscal 2023. Mike Egeck, Chief Executive Officer said, “Following three years of unprecedented growth, the pool industry and Leslie’s faced multiple...

RGC Resources, Inc. Raises Annual Dividend to $0.80 per Share

Written by Customer Service on November 28, 2023. Posted in Dividend Reports And Estimates.

ROANOKE, Va., Nov. 28, 2023 (GLOBE NEWSWIRE) — The Board of Directors of RGC Resources, Inc. (NASDAQ: RGCO), at its meeting on November 27, 2023, declared a quarterly dividend of $0.20 per share on the Company’s common stock. The indicated annual dividend is $0.80 per share, a $0.01 or 1.3% per share increase over the prior annual level. The Company has now increased the annual dividend 20 consecutive years. Paul Nester, CEO of RGC Resources, Inc., stated, “The Roanoke Gas utility continues to deliver solid operational and financial performance. Further, we look forward to seeing the MVP completed in 2024. This dividend increase, our 20th annual increase, reflects our commitment to deliver long-term shareholder value.” The dividend will be paid on February 1, 2024 to shareholders of record on January 17, 2024. This is the Company’s...

Summit Financial Group, Inc. Announces Q4 Common Dividend of $0.22 Per Share

Written by Customer Service on November 28, 2023. Posted in Dividend Reports And Estimates.

MOOREFIELD, W.Va., Nov. 28, 2023 (GLOBE NEWSWIRE) — Summit Financial Group, Inc. (“Summit”) (NASDAQ: SMMF) announces its Board of Directors recently declared a fourth quarter 2023 dividend of $0.22 per share payable on December 29, 2023 to common shareholders of record as of the close of business on December 15, 2023. Summit Financial Group, Inc. is the $4.6 billion financial holding company for Summit Community Bank, Inc. Its talented bankers serve commercial and individual clients throughout West Virginia, the Washington, D.C. metropolitan area, Virginia, Kentucky, Eastern Shore of Maryland and Delaware. Summit’s focus on in-market commercial lending and providing other business banking services in dynamic markets is designed to leverage its highly efficient operations and core deposits in strong legacy locations. Residential...

QNB Corp. Declares Q4 2023 Dividend

Written by Customer Service on November 28, 2023. Posted in Dividend Reports And Estimates.

Quakertown, PA, Nov. 28, 2023 (GLOBE NEWSWIRE) — QUAKERTOWN, PA (November 28, 2023) The Board of Directors of QNB Corp. (OTC Bulletin Board: QNBC), the parent company of QNB Bank, at a regular meeting on November 28, declared a quarterly cash dividend of $0.37 per share. The cash dividend is payable on December 29, 2023, to shareholders of record on December 15, 2023. QNB Corp. offers commercial and retail banking services through the twelve banking offices of its subsidiary, QNB Bank. QNB Corp.’s stock is traded in the over-the-counter market under the symbol “QNBC.” For more information, visit QNB’s website at QNBbank.com. CONTACT: David W. Freeman QNB Bank 2155385600 bschaffer@qnbbank.com

QUEST WATER GLOBAL EXPANDS INTO SOUTH AFRICA

Written by Customer Service on November 28, 2023. Posted in Public Companies.

VANCOUVER, CANADA, Nov. 28, 2023 (GLOBE NEWSWIRE) — QUEST WATER GLOBAL, INC. (OTC Pink: QWTR) (“Quest” and/or the “Company”), an innovative water technology company and developer of the solar-powered AQUAtapTM water purification, desalination, and distribution technology, provides the following global expansion plans. Quest Water Global, Inc. is pleased to announce the establishment of a strategic partnership in South Africa with AQUAtapTM Oasis South Africa (Pty) Ltd. This partnership marks a significant milestone for the Company and is a testament to their commitment to promoting diversity and economic empowerment in the region. AQUAtapTM Oasis South Africa (Pty) Ltd. will have access to Quest Water Global, Inc.’s water technologies, market-driven business model, and expertise, while also benefiting...

Year: 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals